Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07246408 · ClinicalTrials.gov registry record · NA
Intermittent Cottonseed Oil Consumption
A NA study of Overweight and Obesity and Dyslipidemia, sponsored by University of Georgia.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT07246408 is a NA study of Overweight and Obesity and Dyslipidemia that is actively recruiting participants, run by University of Georgia. The registered enrollment target is 75 participants, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07246408, a NA study of Overweight and Obesity and Dyslipidemia, is actively recruiting participants, sponsored by University of Georgia.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
Cardiovascular disease risk factors, including higher BMIs and poor cholesterol profiles, are on the rise and contribute to the United States' growing disease burden. Cottonseed oil (CSO) is found readily in the food supply, and the investigator's previous studies have demonstrated that incorporating CSO into the diet is sufficient to improve fasting and postprandial blood lipids and other markers of chronic disease risk in both healthy and at-risk populations. This study aims to examine the impact of intermittent CSO consumption at different doses (consumed three times per week (3x/wk)) on changes in fasting and postprandial lipid metabolism/blood lipids and markers of chronic disease risk. The specific aims are: \*Examine the impact of intermittent CSO consumption (3x/week) at two different doses on fasting and postprandial lipids. \*Examine the impact of intermittent CSO consumption (3x/week) at two different doses on other markers of chronic disease risk. Participants will be asked to: \*Consume provided meal replacement shakes and snacks 3 times per week for 56 days. \*Attend three bi-weekly (every other week) short visits for fasting blood draws, body measurements, and collection of the next two weeks' study materials. \*Attend two longer (5.5h) testing visits, which include eating a standardized breakfast meal and having blood drawn periodically before and after breakfast. Researchers will compare CSO-30, CSO-20, and Control groups (receiving no oil) to see if intermittent CSO consumption imparts the same health benefits as previously shown with daily doses of CSO.
Conditions Studied
Interventions
- OTHER Control
- OTHER CSO-30
- OTHER CSO-20
Study Locations (1)
Georgia
- University of Georgia - Athens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2026-01-16 |
| Est. Completion | 2029-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07246408
The ClinicalTrials.gov registry entry for NCT07246408 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (67% lower). The listed sponsor is University of Georgia, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Overweight and Obesity appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.
NCT07246408 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT07246408 about?
NCT07246408 is a clinical study titled "Intermittent Cottonseed Oil Consumption". Cardiovascular disease risk factors, including higher BMIs and poor cholesterol profiles, are on the rise and contribute to the United States' growing disease burden. Cottonseed oil (CSO) is found readily in the food supply, and the investigator's previous studies have demonstrated that incorporatin...
What is the current status of trial NCT07246408?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2026-01-16. Estimated completion is 2029-05.
What conditions does trial NCT07246408 study?
This clinical trial studies the following conditions: Overweight and Obesity, Dyslipidemia, Nutrition, Healthy.
What interventions are being tested in trial NCT07246408?
The interventions under investigation include: Control (OTHER), CSO-30 (OTHER), CSO-20 (OTHER).
Who is sponsoring clinical trial NCT07246408?
This trial is sponsored by University of Georgia, which has 59 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07246408 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight and Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dose Response Effects of Pecan Consumption
RECRUITING · NA
-
A Pilot Factorial Trial of an Integrated Lifestyle Intervention
RECRUITING · NA
-
Cottonseed Oil Dose Response
RECRUITING · NA
-
Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
RECRUITING · NA
-
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
RECRUITING · NA
-
Cottonseed Oil Versus Matched PUFA Effects
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.